Literature DB >> 3732081

Otitis media and sinusitis in children. Role of Branhamella catarrhalis.

C D Bluestone.   

Abstract

Otitis media and sinusitis are among the most common diseases of childhood and various treatment approaches have been advocated. This review focuses on current experience in Pittsburgh, both in terms of our methods of patient management and the changing aetiology of the underlying diseases. Special reference is made to the role played by Branhamella catarrhalis and the emergence of beta-lactamase-producing strains. Results from recently completed clinical trials would suggest that antibacterial therapy should be administered to children with these infections, to reduce morbidity and prevent the ever-present supportive complications associated with both diseases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732081     DOI: 10.2165/00003495-198600313-00029

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  14 in total

1.  The immotile-cilia syndrome. A congenital ciliary abnormality as an etiologic factor in chronic airway infections and male sterility.

Authors:  R Eliasson; B Mossberg; P Camner; B A Afzelius
Journal:  N Engl J Med       Date:  1977-07-07       Impact factor: 91.245

2.  beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children.

Authors:  A L Kovatch; E R Wald; R H Michaels
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

3.  Sinus disease in children with respiratory allergy.

Authors:  G S Rachelefsky; M Goldberg; R M Katz; G Boris; M T Gyepes; M J Shapiro; M R Mickey; S M Finegold; S C Siegel
Journal:  J Allergy Clin Immunol       Date:  1978-05       Impact factor: 10.793

4.  Anaerobic infection of the paranasal sinuses.

Authors:  J Frederick; A I Braude
Journal:  N Engl J Med       Date:  1974-01-17       Impact factor: 91.245

5.  Microbiology of recurrent and chronic otitis media with effusion.

Authors:  K H Riding; C D Bluestone; R H Michaels; E I Cantekin; W J Doyle; C S Poziviak
Journal:  J Pediatr       Date:  1978-11       Impact factor: 4.406

6.  Recent advances in the pathogenesis, diagnosis, and management of otitis media.

Authors:  C D Bluestone
Journal:  Pediatr Clin North Am       Date:  1981-11       Impact factor: 3.278

7.  Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor.

Authors:  E R Wald; J S Reilly; M Casselbrant; J Ledesma-Medina; G J Milmoe; C D Bluestone; D Chiponis
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

8.  Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media.

Authors:  P A Shurin; C D Marchant; C H Kim; G F Van Hare; C E Johnson; M A Tutihasi; L J Knapp
Journal:  Pediatr Infect Dis       Date:  1983 Jan-Feb

9.  Bacteriology of the maxillary sinuses in patients with cystic fibrosis.

Authors:  E D Shapiro; G J Milmoe; E R Wald; J B Rodnan; A D Bowen
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

10.  Otitis media with effusion in preschool children.

Authors:  M L Casselbrant; L M Brostoff; E I Cantekin; M R Flaherty; W J Doyle; C D Bluestone; T J Fria
Journal:  Laryngoscope       Date:  1985-04       Impact factor: 3.325

View more
  21 in total

1.  Beware of ciprofloxacin in acute otitis media.

Authors:  C Marone; F Quadri
Journal:  BMJ       Date:  1992-10-10

2.  [Cefixime therapy in sinusitis].

Authors:  W Jorde; M Schata
Journal:  Infection       Date:  1990       Impact factor: 3.553

3.  Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.

Authors:  X X Gu; J Chen; S J Barenkamp; J B Robbins; C M Tsai; D J Lim; J Battey
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 4.  Therapy of acute otitis media. Clinical and economic aspects.

Authors:  R Sagraves; W Maish
Journal:  Pharmacoeconomics       Date:  1994-09       Impact factor: 4.981

Review 5.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.

Authors:  Shengqing Yu; Xin-Xing Gu
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 7.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

8.  A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.

Authors:  M E Helminen; I Maciver; J L Latimer; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 9.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

10.  Evaluation of amoxicillin clavulanate twice daily versus thrice daily in the treatment of otitis media in children. Danish-Swedish Study Group.

Authors:  S Jacobsson; A Fogh; P Larsson; S Lomborg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.